Search results for "POSITRON EMISSION TOMOGRAPHY"

showing 10 items of 235 documents

Predicting the in vivo release from a liposomal formulation by IVIVC and non-invasive positron emission tomography imaging

2010

This study aimed to predict the in vivo performance from the in vitro release of a low-molecular weight model compound, [(18)F]-2-fluoro-2-deoxy-d-glucose ([(18)F]FDG), from liposomes and by means of positron emission tomography (PET). Liposomes composed of hydrogenated phosphatidylcholine (HPC) were prepared by a freeze-thaw method. Particle size distribution was measured by dynamic light scattering (DLS). In vitro release was examined with a dispersion method detecting the radioactivity of [(18)F]FDG. In vivo release of [(18)F]FDG, following i.p. injection of the liposomes in rats, was determined by using a Micro-PET scanner. Convolution was performed to predict the in vivo profiles from …

Liposomemedicine.diagnostic_testbusiness.industryPharmaceutical SciencePharmaceutical formulationModified Release Dosage FormRatschemistry.chemical_compoundIVIVCchemistryDynamic light scatteringFluorodeoxyglucose F18Positron emission tomographyIn vivoPositron-Emission TomographyPhosphatidylcholineLiposomesmedicineAnimalsParticle SizeNuclear medicinebusinessBiomedical engineeringEuropean Journal of Pharmaceutical Sciences
researchProduct

Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications.

2019

Meningiomas account for approximately 30% of all new diagnoses of intracranial masses. The 2016 World Health Organization’s (WHO) classification currently represents the clinical standard for meningioma’s grading and prognostic stratification. However, watchful waiting is frequently the chosen treatment option, although this means the absence of a certain histological diagnosis. Consequently, MRI (or less frequently CT) brain imaging currently represents the unique available tool to define diagnosis, grading, and treatment planning in many cases. Nonetheless, these neuroimaging modalities show some limitations, particularly in the evaluation of skull base lesions. The emerging evidence supp…

Cancer Researchmedicine.medical_specialtypositron emission tomographymedicine.medical_treatmentReviewlcsh:RC254-282meningioma030218 nuclear medicine & medical imagingMeningioma03 medical and health sciences0302 clinical medicineNeuroimagingFunctional neuroimagingmedicineotorhinolaryngologic diseasesMedical diagnosisRadiation treatment planningGrading (tumors)neoplasmsMeningioma; Neuroimaging; Positron emission tomography; Radionuclide therapy; Somatostatin receptorneuroimagingbusiness.industryradionuclide therapylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasesomatostatin receptorOncologymeningioma; somatostatin receptor; neuroimaging; positron emission tomography; radionuclide therapy030220 oncology & carcinogenesisRadionuclide therapyRadiologybusinessWatchful waitingCancers
researchProduct

Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18

2007

At present, there is still no consensus on the choice of the reference area in positron emission tomography (PET) studies of Alzheimer's disease (AD). In this study, PET scans with fluorodeoxyglucose-F18 were carried out in the following groups of subjects: 47 patients with probable AD, 8 patients with mild cognitive impairment, and 15 age-similar healthy subjects. Scans normalized to the cerebral global mean (CGM), cerebellum (CBL), and the primary sensorimotor cortex (SMC). We evaluated the effect of the different count normalization procedures on the accuracy of (18)F-FDG PET to detect AD-specific metabolic abnormalities (voxel-based group comparison) and to differentiate between patient…

MaleNormalization (statistics)Pathologymedicine.medical_specialtyAdolescentNeuroscience (miscellaneous)Neuropsychological TestsStatistical parametric mappingGyrus CinguliSeverity of Illness IndexCentral nervous system diseaseAlzheimer DiseaseFluorodeoxyglucose F18CerebellumParietal LobemedicineHumansDementiaRadiology Nuclear Medicine and imagingAgedFluorodeoxyglucosemedicine.diagnostic_testbusiness.industryCognitive disorderMotor CortexSomatosensory Cortexmedicine.diseaseTemporal LobeFrontal LobePsychiatry and Mental healthPositron emission tomographyPositron-Emission TomographyFemaleRadiopharmaceuticalsAlzheimer's diseaseCognition DisordersNuclear medicinebusinessPsychologymedicine.drugPsychiatry Research: Neuroimaging
researchProduct

2015

We present a method to discover discriminative brain metabolism patterns in [18F] fluorodeoxyglucose positron emission tomography (PET) scans, facilitating the clinical diagnosis of Alzheimer's disease. In the work, the term "pattern" stands for a certain brain region that characterizes a target group of patients and can be used for a classification as well as interpretation purposes. Thus, it can be understood as a so-called "region of interest (ROI)". In the literature, an ROI is often found by a given brain atlas that defines a number of brain regions, which corresponds to an anatomical approach. The present work introduces a semi-data-driven approach that is based on learning the charac…

Multidisciplinarymedicine.diagnostic_testbusiness.industryComputer scienceModel selectionBrain atlasMagnetic resonance imagingPattern recognitionMixture modelmedicine.diseasecomputer.software_genreBrain regionNeuroimagingDiscriminative modelPositron emission tomographyVoxelRegion of interestmedicineArtificial intelligenceAlzheimer's diseaseNuclear medicinebusinesscomputerAlzheimer's Disease Neuroimaging InitiativePLOS ONE
researchProduct

Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imag…

2002

Detection of disease activity in Crohn's disease (CD) is of crucial importance for diagnosis and management of the disease. Noninvasive methods for monitoring are desirable and comprise hydromagnetic resonance imaging (hydro-MRI) and leukocyte scintigraphy. In addition, a recent case report indicated the potential of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) to assess CD activity. However, comparative prospective studies are lacking.Between February, 1999 and August, 2000, 59 patients with CD were enrolled in a prospective study to assess disease activity by FDG-PET, hydro-MRI, and immunoscintigraphy with anti-nonspecific cross-reacting antigen 95 antigranulocyte antibod…

AdultMalePathologymedicine.medical_specialtyGranulocyteScintigraphySensitivity and SpecificityDisease activityFluorodeoxyglucose positron emission tomographyCrohn DiseaseAntigens NeoplasmFluorodeoxyglucose F18medicineHumansProspective StudiesTomography Emission-Computed Single-PhotonCrohn's diseaseMembrane GlycoproteinsHepatologymedicine.diagnostic_testbiologybusiness.industryGastroenterologyAntibodies MonoclonalColonoscopymedicine.diseaseMagnetic Resonance Imagingmedicine.anatomical_structurePositron emission tomographybiology.proteinFemaleTomographyAntibodyRadiopharmaceuticalsbusinessNuclear medicineCell Adhesion MoleculesGranulocytesThe American journal of gastroenterology
researchProduct

The study of myocardial viability after myocardial infarction: Valve and limitations of magnetic resonance imaging compared with myocardial scintigra…

1997

International audience; Abstract: The aim of this study was to compare myocardial thickness measured by magnetic resonance imaging and quantified fixation of thallium. Twenty-one patients 61.2+/-11 years were investigated after myocardial infarction of the anterior wall in 8 cases, inferior in 10 cases, lateral in 2 cases and apical in one case. The mean angiographic ejection fraction was 46.5 +/- 19 %. Myocardial scintigraphy was performed after an exercise or pharmacological stress test and followed by a study of redistribution. The data was analysed by a quantitative method. Magnetic resonance imaging was performed with Vertical and horizontal long axis views in systole and diastole with…

VIABLE MYOCARDIUMF-18 FLUORODEOXYGLUCOSELEFT-VENTRICULAR DYSFUNCTION[ INFO.INFO-IM ] Computer Science [cs]/Medical ImagingCORONARY-ARTERY DISEASEPOSITRON EMISSION TOMOGRAPHYTL-201[INFO.INFO-IM]Computer Science [cs]/Medical Imaging[INFO.INFO-IM] Computer Science [cs]/Medical ImagingTHALLIUM UPTAKEREVASCULARIZATIONREINJECTIONIRREVERSIBLE DEFECTS
researchProduct

Utility of imaging techniques in the diagnosis of oral cancer.

2015

Abstract Purpose Imaging techniques such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) are often used to complement the clinical exploration and staging of oral squamous cell carcinoma (OSCC). Which of these techniques is best in establishing correct staging and treatment planning is not clear, however. This study aims to determine which technique is most appropriate for diagnosing the primary tumor and for detecting bone invasion and neck metastases. Material and methods A Medline literature search was made over the last 10 years. In each selected study, we recorded the sample size and sensitivity, specificity and precision. Strengths…

Pathologymedicine.medical_specialtyFuture studiesComputed tomographyPositron Emission Tomography Computed TomographymedicineHumansBasal cellNeoplasm InvasivenessRadiation treatment planningEarly Detection of CancerNeoplasm Stagingmedicine.diagnostic_testbusiness.industryCancerMagnetic resonance imagingmedicine.diseasePrimary tumorMagnetic Resonance ImagingOtorhinolaryngologyPositron emission tomographyHead and Neck NeoplasmsPositron-Emission TomographyCarcinoma Squamous CellSurgeryMouth NeoplasmsRadiologyOral SurgerybusinessTomography X-Ray ComputedJournal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
researchProduct

Kinetic analysis of functional images: The case for a practical approach to performance prediction

1999

We present the first parallel medical application for the analysis of dynamic positron emission tomography (PET) images together with a practical performance model. The parallel application may improve the diagnosis for a patient (e. g. in epilepsy surgery) because it enables the fast computation of parametric images on a pixed level as opposed to the traditionally used region of interest (ROI) approach which is applied to determine an average parametric value for a particular anatomic region of the brain. We derive the performance model from the application context and show its relation to abstract machine models. We demonstrate the accuracy of the model to predict the runtime of the appli…

medicine.diagnostic_testRelation (database)Computer sciencebusiness.industryComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISIONFunctional imagingPositron emission tomographyRegion of interestPerformance predictionmedicineArtificial intelligencebusinessAlgorithmParametric statistics
researchProduct

New Trends in Detectors for Medical Imaging

2010

The improvement of medical imaging instrumentation is based both on the enhancement of the performance of the detectors employed in their construction and on the development of novel techniques and methods that allow full exploitation of the advantages of the new instrumentation.

medicine.medical_specialtyOpticsmedicine.diagnostic_testPositron emission tomographyOptical photonComputer sciencebusiness.industryDetectormedicineMedical imagingMedical physicsInstrumentation (computer programming)business
researchProduct

Synthesis and preliminary in vivo evaluation of well-dispersed biomimetic nanocrystalline apatites labeled with positron emission tomographic imaging…

2015

In recent years, biomimetic synthetic apatite nanoparticles (AP-NPs), having chemical similarity with the mineral phase of bone, have attracted a great interest in nanomedicine as potential drug carriers. To evaluate the therapeutic perspectives of AP-NPs through the mechanisms of action and organs they interact with, the noninvasive monitoring of their in vivo behavior is of paramount importance. To this aim, here the feasibility to radiolabel AP-NPs ("naked" and surface-modified with citrate to reduce their aggregation) with two positron emission tomographic (PET) imaging agents ([F-18]NaF and Ga-68-NO(2)AP(BP)) was investigated. [F-18]NaF was used for the direct incorporation of the radi…

inorganic chemicalsMalepositron emission tomographyMaterials scienceNanoparticleNanotechnologyPilot ProjectsDiffusionNanocapsulesIn vivoBiomimetic MaterialsApatitesMaterials TestingmedicineAnimalsGeneral Materials ScienceChelationWhole Body ImagingColloidsParticle SizeRats Wistarmedicine.diagnostic_testtechnology industry and agriculturenanomedicinecalcium phosphatesPositron emission tomographyIsotope LabelingPositron-Emission Tomographydrug deliveryDrug deliverySurface modificationNanomedicineFeasibility StudiesNanoparticlesRadiopharmaceuticalsDrug carrierCrystallizationACS applied materialsinterfaces
researchProduct